Набор от данни:  Актуализация на регистрите на НСЦРЛП към 02.09.2016 г.

одобрен

Приложение 4 на ПЛС актуализация 02.09.2016

Уникален идентификатор:  0fe19a2f-8a44-4ec9-9767-4176041b1c2e

здравеопазване лекарства реимбурсиране

Текуща версия: 1

Показвана версия: 1

Формат: CSV

  • Създаден на: 2016-09-20 09:48:55
  • Създаден от: georgi_sivchev
  • Последна промяна: 2018-10-16 08:29:13
  • Последно променил: migrate_data
записа на страница
Подреди по:
Възходящ ред Низходящ ред

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Etanercept EU/1/99/126/003 ENBREL 25 powder and solvent for solution for injection, 25 mg x 4, Powder and solvent for solution for injection, 25, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, Великобритания 926.3 185.26 1111.56 4% 10 936.3 187.26 1123.56 16% 25 961.3 192.26 1153.56 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-397/07.01.2009 30.01.2009 Неактивен 3361
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7900/25.01.2016. 09.02.2016 Активен 3823
Etanercept EU/1/99/126/020 ENBREL 50 mg solution for injection in pre-filled pen 50 mg/ml – 1 ml x 4 pre-filled pens +4 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals New Lane Havant Hampshire, PO9 2NG, Обединено кралство 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-6072/23.04.2015. 08.05.2015 Неактивен 3823
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1405.36 281.07 1686.43 4% 10 1415.36 283.07 1698.43 16% 25 1440.36 288.07 1728.43 НСР-7813/28.12.2015 13.01.2016 Активен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Europe MA EEIG, Обединено Кралство Wyeth Pharmaceuticals, UK 1561.96 312.39 1874.35 4% 10 1571.96 314.39 1886.35 16% 25 1596.96 319.39 1916.35 НСР-5949/01.04.2015. 16.04.2015 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1622.03 324.41 1946.44 4% 10 1632.03 326.41 1958.44 16% 25 1657.03 331.41 1988.44 НСР-3992/30.06.2014 15.07.2014 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1739.08 347.82 2086.9 4% 10 1749.08 349.82 2098.9 16% 25 1774.08 354.82 2128.9 оставена без разглеждане жалба до Комисия по прозрачност с решение на Комисия по прозрачност КП-241/28.06.2013; КЦРР-2426/22.02.2013 16.10.2013 Неактивен 3736
Etanercept EU/1/99/126/017 ENBREL 50 mg solution for injection in pre-filled syringe 50 mg/ml - 1 ml x 4 pre-filled syringes + 8 alcohol swabs, Solution for injection, 50, mg, Pack: 4 Pfizer Limited, Обединено Кралство Wyeth Pharmaceuticals, UK 1852.6 370.52 2223.12 4% 10 1862.6 372.52 2235.12 16% 25 1887.6 377.52 2265.12 промяна в обстоятелствата КЦPP-1521/25.10.2012 КЦ-316/28.11.2008 19.12.2008 Неактивен 3736
Macrogol, combinations 5378/ 13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 10.07 2.01 12.08 6% 0.6 10.67 2.13 12.8 18% 1.81 12.48 2.5 14.98 КЦРР-1094/26.07.2012 10.08.2012 Активен 1310
Macrogol, combinations 5378/13.07.2009 ENDOFALK, Powder for oral solution, 52.5, g, Pack: 6 Dr. Falk Pharma GmbH, Германия Dr. Falk Pharma GmbH - Germany 12.3 2.46 14.76 8% 0.98 13.28 2.66 15.94 20% 2.46 15.74 3.15 18.89 КЦ-1412/22.02.2010 10.03.2010 Неактивен 1310
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 41.46 8.29 49.75 4% 1.66 43.12 8.62 51.74 16% 6.63 49.75 9.95 59.7 КЦРР-2309/20.02.2013 08.03.2013 Активен 1666
Cyclophosphamide II-1255/ 13.12.2007 ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 42.19 8.44 50.63 4% 1.69 43.88 8.78 52.66 16% 6.75 50.63 10.13 60.76 КЦ-950/10.06.2009 30.06.2009 Неактивен 1666
Cyclophosphamide II-1256/13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 3.77 0.75 4.52 7% 0.26 4.03 0.81 4.84 20% 0.75 4.78 0.96 5.74 Цената се вписва в регистъра на пределните цени с решение НСР-2722/06.02.2014 КЦРР-2309/20.02.2013 08.03.2013 Заличен 1667
Cyclophosphamide II-1256/ 13.12.2007 ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 Baxter Oncolcogy GmbH, Германия Baxter Oncology GmbH - Germany 4.19 0.84 5.03 7% 0.29 4.48 0.9 5.38 20% 0.84 5.32 1.06 6.38 КЦ-950/10.06.2009 30.06.2009 Неактивен 1667
Trimetazidine 20110185 Energotrim, Modified‐release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.76 1.55 9.31 7% 0.54 8.3 1.66 9.96 20% 1.55 9.85 1.97 11.82 НСР-3198/07.04.2014; НСР-9769/14.07.2016 02.08.2016. Заличен 2682
Trimetazidine 20110185 Energotrim, Modified‐release tablet, 35, mg, Pack: 60 Sandoz d.d., Словения Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom 7.94 1.59 9.53 7% 0.56 8.5 1.7 10.2 20% 1.59 10.09 2.02 12.11 КЦРР-1718/28.11.2012 г 01.01.2013 Неактивен 2682
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 12.03 2.41 14.44 6% 0.72 12.75 2.55 15.3 18% 2.17 14.92 2.98 17.9 НСР-8323/26.02.2016 16.03.2016 Активен 2998
Hepatitis B, purified antigen 20000247 Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals s.a., Белгия 17.21 3.44 20.65 6% 1.03 18.24 3.65 21.89 18% 3.1 21.34 4.27 25.61 КЦРР-2557/14.03.2013 29.03.2013 Активен 1730
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, Hepatitis B surface antigen - 10 mcg/ 0.5 ml, -, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 12.18 2.44 14.62 6% 0.73 12.91 2.58 15.49 18% 2.19 15.1 3.02 18.12 НСР-3980/30.06.2014 15.07.2014 Неактивен 2998
Hepatitis B, purified antigen 20000246 Engerix B, Suspension for injection, 10 mcg/0,5 ml, mg, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Белгия 10.37 2.07 12.44 6% 0.62 10.99 2.2 13.19 18% 1.87 12.86 2.57 15.43 НСР-2807/17.02.2014 03.03.2014 Активен 2516
Hepatitis B, purified antigen II-10803 / 12.05.2005 г. Engerix B, Suspension for injection, Hepatitis B surface antigen - 20 mcg/ 1.0 ml, -, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 21.01 4.2 25.21 6% 1.26 22.27 4.45 26.72 18% 3.78 26.05 5.21 31.26 КЦ-262/27.10.2008 18.11.2008 Неактивен 1730
Hepatitis B, purified antigen II-10802 / 12.05.2005 г. Engerix B, Suspension for injection, Hepatitis B surface antigen - 10 mcg/ 0.5 ml, -, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium 12.87 2.57 15.44 6% 0.77 13.64 2.73 16.37 18% 2.32 15.96 3.19 19.15 КЦ-262/27.10.2008 18.11.2008 Неактивен 2998
Hepatitis B, purified antigen II-10802/12,05,2005 ENGERIX B, Suspension for injection, Hepatitis B surface antigen (HBsAg) 0,5 ml/10 mcg/ dose, mg, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals, Belgium 10.37 2.07 12.44 6% 0.62 10.99 2.2 13.19 18% 1.87 12.86 2.57 15.43 цената се заличава КЦРР-1638/15.11.2012 КЦ-1514/19.04.2010 07.05.2010 Заличен 915
Hepatitis B, purified antigen II-1111/28.11.2007 ENGERIX B, Suspension for injection, 20 mcg/1.0 ml - 1 dose, mcg, Pack: 1 GlaxoSmithKline Biologicals S.A., Белгия GlaxoSmithKline Biologicals S.A., Belgium 20.5 4.1 24.6 6% 1.23 21.73 4.35 26.08 18% 3.69 25.42 5.08 30.5 цената се заличава КЦРР-1637/15.11.2012 КЦ-1483/31.03.2010 21.04.2010 Заличен 907
Enalapril II-14225/04.09.2006 г. Enpril, Tablet, 10, mg, Pack: 50 Инбиотех ООД, България "Инбиотех" ООД България 3.18 0.64 3.82 7% 0.22 3.4 0.68 4.08 20% 0.64 4.04 0.81 4.85 корек КЦ-1098/03.09.2009 КЦ-1004/25.06.2009 16.07.2009 Активен 782
Показва 2450 до 2474 от общо 9174 записа
Линк за сваляне в CSV формат: Копирай
Линк за сваляне в JSON формат: Копирай
Линк за сваляне в XML формат: Копирай
 

Моля изчакайте